首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1542978

全球筋膜切開術市場 - 2024-2031

Global Fasciotomy Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

全球筋膜切開術市場在2023年達到41.5億美元，預計到2031年將達到66.8億美元，在2024-2031年預測期間複合年成長率為6.3%。

筋膜切開術是一種外科手術，透過切開筋膜來緩解張力或壓力，從而治療由此導致的組織或肌肉區域的血液循環障礙。筋膜切開術是一種用於治療急性筋膜室症候群的保肢手術。它有時也用於治療慢性筋膜室壓力症候群。此手術的成功率非常高，最常見的問題是附近神經的意外損傷。

在手術之前，醫生會進行局部或全身麻醉。外科醫生在受影響的肌肉室上方做一個切口，打開限制性筋膜（厚厚的結締組織），以緩解壓力並增加流向肌肉和神經的血液。如果多塊肌肉受到影響，可能需要多個切口。

市場動態：

司機

骨筋膜室症候群盛行率增加

全球筋膜切開術市場的需求是由多種因素所驅動的。骨筋膜室症候群盛行率的上升推動了市場的成長。

此外，技術進步將推動治療需求。例如，根據 nih.gov，急性骨筋膜室症候群的發生率估計為每 10 萬人中 7.3 例，女性為每 10 萬人中 0.7 例，其中大多數病例發生在創傷後。脛骨幹骨折是急性筋膜室症候群最常見的原因，並且與 1% 至 10% 的急性筋膜室症候群發生率有關。

急性骨筋膜室症候群較常見於 35 歲以下的男性，這可能是由於骨筋膜室內肌肉量相對較大，且受高能創傷的可能性增加。有出血素質的患者，例如血友病，急性骨筋膜室症候群的風險更大。已有兒童白血病急性筋膜室症候群病例報告，但沒有急性誘發性創傷。

限制

與程序相關的高成本以及批准新療法的嚴格監管要求等因素預計將阻礙市場。

細分市場分析

全球筋膜切開術市場根據類型、應用、最終用戶和地區進行細分。

分段植皮筋膜切開器材（STSG）約佔全球筋膜切開市場佔有率的58%

皮膚移植筋膜切開器材（STSG）領域預計將在預測期內佔據最大的市場佔有率。在這一領域，政府監管的發展以及私人製造商研究資金的增加將推動該市場的發展。

例如，2021 年 4 月，美國食品藥物管理局 (FDA) 向 Chemence Medical 重新設計的 Exofin 融合皮膚閉合系統授予 510(k) 批准。 Exofin fusion 提供自黏式軟性網帶和快速固化的氰基丙烯酸 2-辛酯局部黏合劑，可覆蓋和密封切口，同時也形成直接的微生物屏障以防止感染。

市場地理分析

北美約佔全球筋膜切開市場佔有率的42%

預計北美地區將在預測期內佔據最大的市場佔有率。該地區骨筋膜室症候群發病率的上升、技術的進步以及人們意識的不斷增強，有助於推動市場的發展。

例如，根據 clevelandclinic.org 報導，專家估計，美國每年每 10 萬人中不到 10 人患有急性骨筋膜室症候群。然而，這種情況在患有某些類型骨折（骨折）的人中更為常見。例如，研究估計，大約 10% 的脛骨骨折患者會出現骨筋膜室症候群。

例如，2020 年 2 月，生物列印公司 T&R Biofab 宣布與強生醫療器材公司 Ethicon Llc., Inc. 達成新的合作協議。此次合作旨在開發用於傷口治療、重建手術等的 3D 生物列印軟組織支架。

Fasciotomy is a surgical procedure where the fascia is cut to relieve tension or pressure to treat the resulting loss of circulation to an area of tissue or muscle. Fasciotomy is a limb-saving procedure when used to treat acute compartment syndrome. It is also sometimes used to treat chronic compartment stress syndrome. The procedure has a very high rate of success, with the most common problem being accidental damage to a nearby nerve.

Before the procedure, doctors administer regional or general anesthesia. The surgeon makes an incision above the affected muscle compartment, opening the restrictive fascia-thick sheets of connective tissue-to relieve pressure and increase blood flow to muscles and nerves. More than one incision may be required if multiple muscles are affected.

Market Dynamics: Drivers

Increasing prevalence of compartment syndrome

The demand for the global fasciotomy market is driven by multiple factors. The rising prevalence of compartment syndrome propels the market growth.

Furthermore, the demand for treatment will be fueled by technological advancements. For instance, according to nih.gov, The incidence of acute compartment syndrome is estimated to be 7.3 per 100,000 in males and 0.7 per 100,000 in females, with the majority of cases occurring after trauma. Tibial shaft fracture is the most common cause of acute compartment syndrome and is associated with a 1 to 10 percent incidence of acute compartment syndrome.

Acute compartment syndrome occurs more commonly in males younger than 35, which may be due to a larger relative intracompartmental muscle mass and increased likelihood of being involved in high-energy trauma. Patients with bleeding diathesis, such as hemophilia, are at greater risk for acute compartment syndrome. Cases of acute compartment syndrome have been reported without acute precipitating trauma in pediatric leukemia.

Restraints

Factors such as high costs associated with the procedure and stringent regulatory requirements for the approval of new treatments are expected to hamper the market.

Market Segment Analysis

The global fasciotomy market is segmented based on type, application, end-user, and region.

The segment skin graft fasciotomy instrument (STSG) accounted for approximately 58% of the global fasciotomy market share

The skin graft fasciotomy instrument (STSG) segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and rising funds for private manufacturers for research would drive this market.

For instance, in April 2021, the US Food and Drug Administration (FDA) granted 510(k) approval to Chemence Medical's redesigned Exofin fusion skin closure system. Exofin fusion offers a self-adhering, flexible mesh strip and a rapidly curing 2-octyl cyanoacrylate topical adhesive, which covers and seals incisions while also creating an immediate microbial barrier to protect against infections.

Market Geographical Analysis

North America accounted for approximately 42% of the global fasciotomy market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of compartment syndrome, technological advancements, and growing awareness among people, in this region, help to propel the market.

For instance, according to clevelandclinic.org, experts estimate that fewer than 10 in every 100,000 people in the U.S. experience acute compartment syndrome each year. However, it's much more common in people who have some types of bone fractures (broken bones). For example, studies estimate that around 10% of people who break their tibia develop compartment syndrome.

For instance, in February 2020, Bioprinting company T&R Biofab announced a new collaboration agreement with Ethicon Llc., Inc., a Johnson & Johnson Medical Device Company. The partnership aims to develop a 3D bioprinted soft tissue scaffold for wound treatments, reconstructive surgery, and more.

Market Segmentation

By Instrument

Skin Graft Fasciotomy Instrument (STSG)
Negative Pressure Wound Treatment Fasciotomy Instrument (NPWT)
Vascular Ring Technique Fasciotomy Instrument
Continuous External Tissue Expansion Fasciotomy Instrument (CETE)
Others

By Application

Plantar Fasciitis
Acute Compartment Syndrome
Chronic Compartment Syndrome
Others

By End-User

Hospitals
Specialty Clinics
Ambulatory and Surgery Centers
Others

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Market Competitive Landscape

The major global players in the global fasciotomy market include Zipline Medical Inc., Stryker Corporation, DermaClose, Terumo Corporation, Merit Medical Systems, Ethicon Llc., Cardinal Health, 3M, Biopro Inc., and Southmedic Inc. among others.

Key Developments

In June 2022, Advanced Medical Solutions, a specialist in tissue-healing technologies, received FDA 510(k) approval for LiquiBand XL, a new device that can close longer wounds. The device consists of a surgical mesh which is used to close the wound and LiquiBand glue which is used to strengthen the closure and prevent infection.
In May 2024, SouthMedic, a leading manufacturer of surgical blades, scalpels, and innovative medical devices, announced its partnership with Nano Surgical to become the exclusive master distributor of Lumohs MD no. 3 Lighted Scalpel Handles in Canada.

Why Purchase the Report?

To visualize the global fasciotomy market segmentation based on type, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global fasciotomy market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.

The global fasciotomy market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Compartment Syndrome
  - 4.1.1.2. Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Procedure
  - 4.1.2.2. Stringent Regulatory Requirements
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Skin Graft Fasciotomy Instrument*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Negative Pressure Wound Treatment Fasciotomy Instrument
6.4. Vascular Ring Technique Fasciotomy Instrument
6.5. Continuous External Tissue Expansion Fasciotomy Instrument
6.6. Vistide
6.7. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Plantar Fascitis*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Acute Compartment Syndrome
7.4. Chronic Compartment Syndrome
7.5. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory and Surgery Centers
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Zipline Medical Inc. *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Stryker Corporation
11.3. DermaClose
11.4. Terumo Corporation
11.5. Merit Medical Systems
11.6. Ethicon Llc.
11.7. Cardinal Health
11.8. 3M
11.9. Biopro Inc.
11.10. Southmedic Inc. (*LIST NOT EXHAUSTIVE)